iRhythm Technologies, Inc. (IRTC) Financial Statements (2025 and earlier)

Company Profile

Business Address 699 8TH STREET
SAN FRANCISCO, CA 94103
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:320,256317,178165,46375,80677,460110,185
Short-term investments145,311115,9562,49610,90548,67197,591
Other undisclosed cash, cash equivalents, and short-term investments174,945201,222162,96764,90128,78912,594
Receivables80,63979,94177,42785,51389,71261,484
Inventory, net of allowances, customer advances and progress billings14,33614,03915,03215,42514,87313,973
Inventory14,33614,03915,03215,42514,87313,973
Other undisclosed current assets220,782234,661369,987500,764505,41045,170
Total current assets:636,013645,819627,909677,508687,455230,812
Noncurrent Assets
Operating lease, right-of-use asset46,17147,56445,57046,83348,07349,317
Property, plant and equipment130,850125,092122,390117,572112,274104,114
Long-term investments and receivables62,74561,90259,059   
Long-term investments62,74561,90259,059   
Intangible assets, net (including goodwill)862862862862862862
Goodwill862862862862862862
Restricted cash and investments8,3588,3588,3588,3588,358 
Other noncurrent assets41,09941,85245,54068,05252,73348,039
Total noncurrent assets:290,085285,630281,779241,677222,300202,332
TOTAL ASSETS:926,098931,449909,688919,185909,755433,144
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities91,92292,12181,55179,36578,48488,905
Accounts payable11,9467,2217,59313,4258,4405,543
Accrued liabilities79,97684,90073,95865,94070,04483,362
Deferred revenue3,2822,9323,0313,1463,0683,306
Other undisclosed current liabilities16,14015,86715,52215,38415,28915,159
Total current liabilities:111,344110,920100,10497,89596,841107,370
Noncurrent Liabilities
Long-term debt and lease obligation647,237646,443645,821644,977644,07634,950
Long-term debt, excluding current maturities647,237646,443645,821644,977644,07634,950
Liabilities, other than long-term debt80,85283,17891,99777,12478,54880,727
Other liabilities8,7278,57917,9789409081,012
Operating lease, liability72,12574,59974,01976,18477,64079,715
Total noncurrent liabilities:728,089729,621737,818722,101722,624115,677
Total liabilities:839,433840,541837,922819,996819,465223,047
Equity
Equity, attributable to parent86,66590,90871,76699,18990,290210,097
Common stock323131313131
Treasury stock, value(25,000)(25,000)(25,000)(25,000)(25,000) 
Additional paid in capital901,085874,607854,363835,356806,621855,784
Accumulated other comprehensive income (loss)143165(66)182(89)(112)
Accumulated deficit(789,595)(758,895)(757,562)(711,380)(691,273)(645,606)
Total equity:86,66590,90871,76699,18990,290210,097
TOTAL LIABILITIES AND EQUITY:926,098931,449909,688919,185909,755433,144

Income Statement (P&L) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Revenues158,677164,325147,538148,047131,929132,511
Cost of revenue(49,461)(49,257)(46,062)(44,576)(44,413)(45,085)
Gross profit:109,216115,068101,476103,47187,51687,426
Operating expenses(141,772)(119,151)(151,779)(126,452)(125,654)(126,608)
Operating loss:(32,556)(4,083)(50,303)(22,981)(38,138)(39,182)
Nonoperating income2,5212,9014,3096,3802,952 
Investment income, nonoperating4,9195,7406,456   
Other nonoperating income8754811,1826,3802,952 
Interest and debt expense(3,273) (3,329)(3,312)(10,449)(941)
Other undisclosed income from continuing operations before equity method investments, income taxes      6,155
Loss from continuing operations before equity method investments, income taxes:(33,308)(1,182)(49,323)(19,913)(45,635)(33,968)
Other undisclosed income (loss) from continuing operations before income taxes3,273 3,329  (4,476)
Loss from continuing operations before income taxes:(30,035)(1,182)(45,994)(19,913)(45,635)(38,444)
Income tax expense (benefit)(665)(151)(188)(194)(32)(255)
Net loss available to common stockholders, diluted:(30,700)(1,333)(46,182)(20,107)(45,667)(38,699)

Comprehensive Income ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Net loss:(30,700)(1,333)(46,182)(20,107)(45,667)(38,699)
Comprehensive loss:(30,700)(1,333)(46,182)(20,107)(45,667)(38,699)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(22)231(248)27123(97)
Comprehensive loss, net of tax, attributable to parent:(30,722)(1,102)(46,430)(19,836)(45,644)(38,796)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: